The impact of magnesium sulfate administration on outcomes in ICU patients with acute myocardial infarction: a retrospective cohort study
Frontiers in Pharmacology · 25.05.2026 · 17
DOI: 10.3389/fphar.2026.1776926 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Pharmacology, online erschienen am 25.05.2026. Verfasst von Guibao Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Huian County Hospital, Quanzhou, Fujian, China. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Intensivpflege
Abstract (Originalsprache)
Background
Although magnesium acts as a natural calcium antagonist with theoretical cardioprotective effects, its clinical value in critically ill patients with acute myocardial infarction (AMI) remains controversial. This study aimed to evaluate the impact of intravenous magnesium sulfate on ICU mortality in this population, and to explore potential dose-response relationships and effect modifiers.
Methods
This retrospective cohort study utilized the single-center Medical Information Mart for Intensive Care-IV version 3.1 (MIMIC-IV v3.1) database, which comprises patients admitted to Beth Israel Deaconess Medical Center, to examine the association between intravenous magnesium sulfate administration and mortality in critically ill patients with AMI. The primary endpoint was ICU mortality. Multivariable Cox regression, propensity score matching, and propensity score weighting were employed to control for confounders and estimate the independent effect of magnesium sulfate administration. Additional analyses included assessment of the restricted mean survival time (RMST) and quantitative evaluation of unmeasured confounding using the E-value.
Results
This study included 5,650 critically ill patients with AMI. In the propensity score-matched analysis, intravenous magnesium sulfate administration was associated with a 45% reduction in ICU mortality risk (HR 0.55, 95% CI 0.42–0.71). RMST analysis confirmed an absolute survival benefit of 1.64 days at 14 days. A consistent reduction in mortality risk was observed across all secondary endpoints. A clear dose-response relationship was identified, with the greatest survival benefit at moderate cumulative doses (2.0–8.0 g) and treatment durations (1.08–3.21 days). The association remained robust to potential unmeasured confounding (E-value = 2.66). Subgroup analyses demonstrated consistent protective effects across all patient strata.
Conclusion
Intravenous magnesium sulfate administration is associated with lower ICU mortality in critically ill patients with AMI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Huian County Hospital, Quanzhou, Fujian, China.
- Department of Pulmonary and Critical Care Medicine, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
- Department of Respiratory Intensive Care Unit, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
- Department of Critical Care, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Zitieren
APA
Jiang, G., Zhuang, G., Zhao, H., Su, R., Niu, X., Wang, L., Wu, J., Liu, J., Zhang, J., Li, W., Yang, Q., & Ding, R. (2026). The impact of magnesium sulfate administration on outcomes in ICU patients with acute myocardial infarction: a retrospective cohort study. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1776926
Vancouver
Jiang G, Zhuang G, Zhao H, Su R, Niu X, Wang L, et al. The impact of magnesium sulfate administration on outcomes in ICU patients with acute myocardial infarction: a retrospective cohort study. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1776926
BibTeX
@article{Jiang2026,
author = {Jiang, Guibao and Zhuang, Gangzhi and Zhao, Hui and Su, Rui and Niu, Xin and Wang, Liqiong and Wu, Jiayu and Liu, Jia and Zhang, Jianchuan and Li, Wengui and Yang, Qilin and Ding, Rong},
title = {The impact of magnesium sulfate administration on outcomes in ICU patients with acute myocardial infarction: a retrospective cohort study},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1776926}
}
EUVIMED